Overview

Veterinary Diagnostics Market is predicted to value over USD 4.1 billion by 2027 end with a CAGR of over 9.2% during the forecast period 2020 to 2027.

Rising expenditure on animal healthcare, increased number of vet practitioners and rising prevalence of zoonotic diseases are some of the factors driving the veterinary diagnostics market growth. Moreover, a rise in the number of pet adoptions across the world shall further boost the market proliferation. As per the APPA survey, 2017, the canine population United States increased from over 69 million in 2012 to over 89 million in 2016 while the feline population witnessed a rise of over 6 million from 2012 to 2016. Additionally, the pet industry expenditure in the United States was projected to be over USD 70 million in 2017. 
Increased usage of latest technologies like fluorometric diagnostics, wearables, biosensors, nanotechnology and biomarkers along with in vitro diagnostics has significantly boosted the market growth. Furthermore, many key players are heavily investing on expanding their manufacturing facilities which shall increase the veterinary diagnostics market demand in developing regions. For example, Henry Schein in July 2017 announced a new website that provided e-commerce solutions that are improvised with an effective process for ordering medical, animal health and dental products for improving the user online experience. 
The emerging nations like India, Brazil are highly populated with farm and companion animals. However, the expenditure assigned to animal healthcare is relatively lower than developed nations. This is primarily due to a dearth of awareness amongst veterinary practitioners and pet owners regarding healthcare services provided to animals. Furthermore, veterinary diagnostic products are manufactured considering the North America and European markets which make them expensive for pet owner from developing markets, thereby posing a steep challenge to the market growth.  

Market Segmentation:

By Product
• Instruments
• Consumables
By Technology
• Immunodiagnostics
  o ELISA Tests
  o Allergen-specific Immunodiagnostic Tests
  o Immunoassay Analyzers
  o Other Immunodiagnostic Products
• Clinical Biochemistry
  o Glucose Monitoring
  o Blood Gas & Electrolyte Analysis
• Molecular Diagnostics
  o Polymer Chain Reaction (PCR) Tests
  o Microarrays
  o Other Molecular Diagnostic Products
• Hematology
  o Hematology Cartridges
  o Hematology Analyzers
• Urinalysis
  o Urinalysis Clips & Cartridges/ Panels
  o Urine Analyzers
  o Urine Test Strips
• Other Veterinary Diagnostic Technologies
By Animal Type
• Companion Animals
  o Dogs
  o Cats
  o Horses
  o Other Companion Animals
• Livestock Animals
  o Cattle
  o Pigs
  o Poultry
  o Other Livestock Animals
By End User
• Veterinary Reference Laboratories
• Veterinary Hospitals and Clinics
• Point-of-care/In-house Testing
• Research Institutes and Universities
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into product, technology, animal type, end user and region. The product segment is fragmented into instruments and consumables. The consumables segment is predicted to hold the veterinary diagnostics market share owing to a rise in the usage of consumables in healthcare settings. The technology segment is categorised into clinical biochemistry, urinalysis, immunodiagnostics, molecular diagnostics and haematology. 
The animal type segment is bifurcated into livestock animals and companion animals. The livestock animals are further divided into cattle, poultry, pigs and horses while the companion animals are further classified into dogs and cats. The companion animal segment is anticipated to lead the market during the forecast period owing to a rise in the number of pet owners in developed nations like the United States where the annual expenditure for animal healthcare has escalated in recent years. The end user segment is fragmented into veterinary reference laboratories, veterinary hospitals and clinics, point of care/in-housing testing and research institutes and universities.

Regional Analysis:

The North America region is anticipated to subjugate the market during the forecast period owing to a rise in the number of companion animal owners coupled with advancements in the veterinary healthcare infrastructure. 

Competitive Landscape:                            

Some of the key market players are IDEXX Laboratories, Abaxis, Zoetis, Qiagen N.V., Thermo Fisher Scientific, Neogen Corporation, Heska Corporation, Virbac, Biomérieux SA, Idvet, Randox Laboratories.  

IDEXX announced its catalyst SDMA in January 2018 for analysing the functionality of kidney in companion animals. Furthermore, Randox Laboratories announced Vivalytic in April 2018 under the molecular diagnostics analyser division. Similarly, Zoetis in April 2018, established sustainable animal healthcare infrastructure in underdeveloped economies like Nigeria, Ethiopia and Uganda and this initiative was funded by the Bill & Melinda Gates Foundation.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global veterinary diagnostics market by product, by technology, by animal type, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions 

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1 Objectives of the Study 
        1.2 Market Definition 
        1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
        1.4 Currency
        1.5 Limitations 
        1.6 Stakeholders     

2. Research Methodology 
        2.1 Research Data 
              2.1.1 Secondary Data
                      2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                      2.1.2.1 Key Data from Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  

3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights

4. Market Variables, Trends & Scope
        4.1 Market Lineage Outlook
        4.2 Penetration and Growth Prospect Mapping
        4.3 Industry Value Chain Analysis
        4.4 Cost Analysis Breakdown
        4.5 Technology Overview
        4.6 Regulatory Framework on Country Level
             4.6.1 Reimbursement Framework    
             4.6.2 Standards and Compliances

5. Market Overview
        5.1 Market Dynamics
              5.1.1 Market Driver Analysis         
              5.1.2 Market Restraint Analysis         
              5.1.3 Industry Challenges                 

6. Market Analysis tools                     
        6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
        6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape

7. Global Veterinary Diagnostics Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Instruments
   7.2. Consumables

8. Global Veterinary Diagnostics Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
   8.1. Immunodiagnostics
        8.1.1. ELISA Tests
        8.1.2. Allergen-specific Immunodiagnostic Tests
        8.1.3. Immunoassay Analyzers
        8.1.4. Other Immunodiagnostic Products
   8.2. Clinical Biochemistry
        8.2.1. Glucose Monitoring
        8.2.2. Blood Gas & Electrolyte Analysis
   8.3. Molecular Diagnostics
        8.3.1. Polymer Chain Reaction (PCR) Tests
        8.3.2. Microarrays
        8.3.3. Other Molecular Diagnostic Products
   8.4. Hematology
        8.4.1. Hematology Cartridges
        8.4.2. Hematology Analyzers
   8.5. Urinalysis
        8.5.1. Urinalysis Clips & Cartridges/ Panels
        8.5.2. Urine Analyzers
        8.5.3. Urine Test Strips
   8.6. Other Veterinary Diagnostic Technologies

9. Global Veterinary Diagnostics Market, By Animal Type Historical Analysis and Forecast 2020-2027 (USD Million)
   9.1. Companion Animals
        9.1.1. Dogs
        9.1.2. Cats
        9.1.3. Horses
        9.1.4. Other Companion Animals
   9.2. Livestock Animals
        9.2.1. Cattle
        9.2.2. Pigs
        9.2.3. Poultry
        9.2.4. Other Livestock Animals

10. Global Veterinary Diagnostics Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
    10.1. Veterinary Reference Laboratories
    10.2. Veterinary Hospitals and Clinics
    10.3. Point-of-care/In-house Testing
    10.4. Research Institutes and Universities

11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                11.2.1. U.S.
                11.2.2. Canada
                11.2.3. Mexico 
                11.2.4. Rest of North America
         11.3 Market Size (USD Mn) Forecast for North America 2020-2027

12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Regional Market Trends
         12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.3.1. Brazil
                12.3.2. Venezuela
                12.3.3. Argentina
                12.3.4. Rest of Latin America
         12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027

13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
               13.2.1. Germany
                13.2.2. U.K
                13.2.3. France
                13.2.4. Italy
                13.2.5 Switzerland
                13.2.6. Spain
                13.2.7. Russia
                13.2.8. Poland
                13.2.9. Rest of Western Europe
         13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027

14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         14.1 Introduction
         14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 14.2.1 Japan
                 14.2.2 China
                 14.2.3 Singapore
                 14.2.4 Korea         
                 14.2.5 India
                 14.2.6 Australia and New Zealand
                 14.2.7 ASEAN
                 14.2.8 Rest of Asia Pacific
         14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027

15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    15.1 Introduction
        15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
        15.2.1 UAE
        15.2.2 South Africa
        15.2.3 Egypt
        15.2.4 Saudi Arabia
        15.2.5 Rest of MEA
    15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    16.1 IDEXX Laboratories
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 Abaxis
              16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.2.2. Product Portfolio
              16.2.3. SWOT Analysis
              16.2.4. Financial Overview
              16.2.5. Strategic Overview    
    16.3 Zoetis
              16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.3.2. Product Portfolio
              16.3.3. SWOT Analysis
              16.3.4. Financial Overview
              16.3.5. Strategic Overview
    16.4 QIAGEN N.V.
             16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.4.2. Product Portfolio
             16.4.3. SWOT Analysis
             16.4.4. Financial Overview
             16.4.5. Strategic Overview
    16.5 Thermo Fisher Scientific
              16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.5.2. Product Portfolio
              16.5.3. SWOT Analysis
              16.5.4. Financial Overview
              16.5.5. Strategic Overview
    16.6 Randox Laboratories
              16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.6.2. Product Portfolio
              16.6.3. SWOT Analysis
              16.6.4. Financial Overview
              16.6.5. Strategic Overview
    16.7 Neogen Corporation
              16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.7.2. Product Portfolio
              16.7.3. SWOT Analysis
              16.7.4. Financial Overview
              16.7.5. Strategic Overview
    16.8 Heska Corporation
             16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.8.2. Product Portfolio
             16.8.3. SWOT Analysis
             16.8.4. Financial Overview
             16.8.5. Strategic Overview
    16.9 Virbac
              16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.9.2. Product Portfolio
              16.9.3. SWOT Analysis
              16.9.4. Financial Overview
              16.9.5. Strategic Overview
    16.10 Biomérieux SA
              16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.10.2. Product Portfolio
              16.10.3. SWOT Analysis
              16.10.4. Financial Overview
              16.10.5. Strategic Overview
    16.11 Idvet
              16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.11.2. Product Portfolio
              16.11.3. SWOT Analysis
              16.11.4. Financial Overview
              16.11.5. Strategic Overview

17. Impact of COVID-19
      17.1. Positive influence on the healthcare industry
      17.2. The financial disruption of the manufacturing sector
      17.3. Impact of COVID-19 on emerging companies
      17.4. Significant mandates in the healthcare regulations initiated by administrations
      17.5. The overall economic slowdown of the developing and developed nations

18. Competitive Intelligence and Competitive Matrix
      18.1 Competitive Intelligence
      18.2 Competitive Matrix

19. Major Deals and Strategic Alliances Analysis
      19.1 Joint ventures
      19.2 Mergers and acquisitions              
      19.3 Licensing and partnerships
      19.4 Technology Collaborations
      19.5 Strategic Divestments
      19.6 Market Entry Strategies                        

20. Relevant Case Studies and Latest News Updates

21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures